MEDICOTRONIX
ActiveSummary
MEDICOTRONIX has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,821 and a net result of -€2,816. Equity is shrinking by about 3.6% per year across the filed financial years. Its solvency ranks better than 41% of 13,668 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- MEDICOTRONIX
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, 3.Siège” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Avec ou sans limitation, sans limitation à défaut d'indication, un ou plusieurs administrateurs” (deed in French)“Fixe ou proportionnelle, 14” (deed in French)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “12, considérés comme donnant agrément” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Monday of May at 16:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Assemblée générale, formes modifications statuts” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Assemblée détermine le cas échéant, après confirmation Tribunal de l'Entreprise compétent” (deed in French)